Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), Nephrology and Urology Units, University of Bari Aldo Moro, Bari, Italy.
Nephrology Unit, "S.S. Annunziata" Hospital, Taranto, Italy.
Eur J Intern Med. 2024 Jun;124:22-31. doi: 10.1016/j.ejim.2024.02.015. Epub 2024 Mar 8.
The Complement System is an evolutionarily conserved component of immunity that plays a key role in host defense against infections and tissue homeostasis. However, the dysfunction of the Complement System can result in tissue damage and inflammation, thereby contributing to the development and progression of various renal diseases, ranging from atypical Hemolytic Uremic Syndrome to glomerulonephritis. Therapeutic interventions targeting the complement system have demonstrated promising results in both preclinical and clinical studies. Currently, several complement inhibitors are being developed for the treatment of complement-mediated renal diseases. This review aims to summarize the most recent insights into complement activation and therapeutic inhibition in renal diseases. Furthermore, it offers potential directions for the future rational use of complement inhibitor drugs in the context of renal diseases.
补体系统是一种进化上保守的免疫成分,在宿主防御感染和组织稳态方面发挥着关键作用。然而,补体系统的功能障碍可导致组织损伤和炎症,从而促成各种肾脏疾病的发生和进展,范围从非典型溶血尿毒症综合征到肾小球肾炎。针对补体系统的治疗干预在临床前和临床研究中均显示出良好的效果。目前,正在开发几种补体抑制剂来治疗补体介导的肾脏疾病。本综述旨在总结补体激活和治疗抑制在肾脏疾病中的最新见解,并为未来在肾脏疾病中合理使用补体抑制剂药物提供潜在方向。